Stock Analiz

Elevance Health, Inc. (ELV) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Elevance Health’s revenue went from $84.9B in fiscal 2016 to $199.1B in fiscal 2025, growth of about 9.9% a year.

Net income in fiscal 2025 was $5.7B, a net margin of 2.8%; the best year in this period was 2021 with $6.2B.

Over the twelve months to September 30, 2026, revenue was $201.8B and net income $5.1B.

Free cash flow was $3.2B in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count fell 16% over the period (buybacks).

Revenue, profit and cash flow by year

Revenue
2016: $84.9B162017: $90.0B172018: $92.1B182019: $104.2B192020: $121.9B202021: $138.6B212022: $156.6B222023: $171.3B232024: $177.0B242025: $199.1B25$199.1B
Net income
2016: $2.5B162017: $3.8B172018: $3.8B182019: $4.8B192020: $4.6B202021: $6.2B212022: $5.9B222023: $6.0B232024: $6.0B242025: $5.7B25$5.7B
Free cash flow
2016: $2.7B162017: $3.4B172018: $2.6B182019: $5.0B192020: $9.7B202021: $7.3B212022: $7.2B222023: $6.8B232024: $4.6B242025: $3.2B25$3.2B
EPS (diluted)
2016: $9.21162017: $14.35172018: $14.19182019: $18.47192020: $17.98202021: $24.95212022: $24.28222023: $25.22232024: $25.68242025: $25.2125$25.21

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$201.8B$199.1B$177.0B$171.3B$156.6B$138.6B$121.9B$104.2B$92.1B$90.0B$84.9B
Gross profit$179.7B$177.9B$157.3B$154.0B$143.6B$127.7B$112.9B$102.2B$92.1B$90.0B—
Operating income$5.4B$7.2B$7.9B$8.5B$8.3B$7.6B$6.4B$6.0B$5.4B$4.2B$4.8B
Net income$5.1B$5.7B$6.0B$6.0B$5.9B$6.2B$4.6B$4.8B$3.8B$3.8B$2.5B
EPS (diluted)$23.52$25.21$25.68$25.22$24.28$24.95$17.98$18.47$14.19$14.35$9.21
R&D———————————
Revenue growth—+12.5%+3.3%+9.4%+13.0%+13.8%+16.9%+13.2%+2.3%+6.1%+7.2%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$7.6B$4.3B$5.8B$8.1B$8.4B$8.4B$10.7B$6.1B$3.8B$4.2B$3.3B
Capital spending-$1.1B-$1.1B-$1.3B-$1.3B-$1.2B-$1.1B-$1.0B-$1.1B-$1.2B-$791M-$584M
Free cash flow$6.5B$3.2B$4.6B$6.8B$7.2B$7.3B$9.7B$5.0B$2.6B$3.4B$2.7B
Dividends paid$1.5B$1.5B$1.5B$1.4B$1.2B$1.1B$954M$818M$776M$705M$684M
Buybacks$2.2B$2.6B$2.9B$2.7B$2.3B$1.9B$2.7B$1.7B$1.7B$2.0B$0
Stock-based pay$240M$276M$191M$289M$264M$255M$283M$294M$226M$170M$165M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$35.4B$33.5B$36.1B$33.3B$31.1B$29.2B$24.6B$20.6B$21.0B$21.2B
Debt—$32.6B$31.7B$25.7B$24.8B$23.8B$21.0B$19.4B$18.1B$18.7B$15.3B
Equity—$43.9B$41.3B$39.3B$36.2B$36.1B$33.2B$31.7B$28.5B$26.5B$25.1B
Total assets—$121.5B$116.9B$108.9B$102.8B$97.5B$86.6B$77.5B$71.6B$70.5B$65.1B
Shares (diluted)218M225M233M237M243M247M254M260M264M268M268M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin89.0%89.4%88.8%89.9%91.7%92.1%92.7%98.1%100.0%100.0%—
Operating margin2.7%3.6%4.4%5.0%5.3%5.5%5.2%5.8%5.9%4.6%5.7%
Net margin2.5%2.8%3.4%3.5%3.8%4.4%3.8%4.6%4.1%4.3%2.9%
FCF margin3.2%1.6%2.6%4.0%4.6%5.2%7.9%4.8%2.8%3.8%3.2%
ROIC—8.0%8.1%10.2%10.5%9.7%8.6%9.4%8.6%9.0%6.5%
ROE—12.9%14.5%15.2%16.3%17.1%13.8%15.2%13.1%14.5%9.8%

Frequently asked questions

What is Elevance Health’s annual revenue?

$199.1B in fiscal 2025 and $201.8B over the twelve months to September 30, 2026.

How much profit does Elevance Health make?

Net income was $5.7B in fiscal 2025 (net margin 2.8%).

Is Elevance Health’s revenue growing?

Yes: revenue rose 12.5% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.